Adaptive Biotechnologies Corporation
ADPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,280,387 | $1,771,759 | $1,108,519 | $882,610 |
| - Cash | $55,034 | $43,163 | $50,646 | $47,920 |
| + Debt | $213,641 | $84,370 | $86,900 | $89,387 |
| Enterprise Value | $2,438,994 | $1,812,966 | $1,144,773 | $924,077 |
| Revenue | $93,973 | $58,879 | $52,443 | $47,459 |
| % Growth | 59.6% | 12.3% | 10.5% | – |
| Gross Profit | $75,816 | $40,880 | $35,464 | $29,414 |
| % Margin | 80.7% | 69.4% | 67.6% | 62% |
| EBITDA | $16,922 | -$18,143 | -$29,604 | -$26,317 |
| % Margin | 18% | -30.8% | -56.4% | -55.5% |
| Net Income | $9,546 | -$25,614 | -$29,852 | -$33,692 |
| % Margin | 10.2% | -43.5% | -56.9% | -71% |
| EPS Diluted | 0.06 | -0.17 | -0.2 | -0.23 |
| % Growth | 135.3% | 15% | 13% | – |
| Operating Cash Flow | -$7,127 | -$12,430 | -$28,484 | -$12,491 |
| Capital Expenditures | -$409 | -$655 | -$1,259 | -$80 |
| Free Cash Flow | -$7,536 | -$13,085 | -$29,743 | -$12,571 |